Canopy Growth Corp. has signed a deal to buy Quebec-based MTL Cannabis Corp. in a transaction valued at about $125 million.
The deal is expected to help boost Canopy Growth’s position in Canada’s medical cannabis market.
Canopy Growth chief executive Luc Mongeau says MTL’s cultivation expertise, combined with his company’s scale, positions it to improve product quality, expand supply and accelerate its path to profitable growth.
(Sponsored)
Ottawa businesses critically important to ending youth homelessness across the city
Local businesses joining United Way East Ontario’s effort to prevent and end youth homelessness not only helps build a stronger, safer, and healthier community, but gives a boost to Ottawa’s
How The Ottawa Hospital uses AI tools to boost health outcomes and streamline clinical efficiency
Dr. Douglas Manuel says it all began with the Ottawa Ankle Rules algorithm, a set of clinical guidelines developed in the early 1990s by The Ottawa Hospital’s Dr. Ian Stiell
Under the terms of the agreement, MTL shareholders will receive 0.32 of a common share of Canopy Growth and 14.4 cents in cash for each MTL share they hold.
Canopy shares closed at $2.40 on the Toronto Stock Exchange on Friday.
The deal requires regulatory and MTL shareholder approval. Closing of the transaction is expected to occur before the end of February.
This report by The Canadian Press was first published Dec. 15, 2025.
